The American Society of Health-System Pharmacists released new guidelines for responding to drug shortages, as well as best practices to improve quality of patient care.

Laval, Canada-based Valeant Pharmaceuticals, a manfucterer of  dermatology, gastrointestinal disorders, eye health and branded generics changed its name to Bausch Health Companies.

Diamond Orthopedic received FDA 510(k) clearance for its sterile-packaged faceted bone screw technology.

Henry Schein moved five spots in the Fortune 500 rankings, going from No. 243 in 2017 to No. 238 in 2018.

Health systems must make point of service compliance a top concern, according to Spend Matters Lead Analyst and Editor Tom Finn.

Boston Scientific officially acquired NxThera, the company behind the Rezum system.

Hospitals implementing value-based care practices can often recover modest amounts of spending, but to realize these savings facilities must be mindful of how quality, finance and analytics transverse the value-based continuum.

Specialty biopharmaceutical company pSivida acquired Icon Biosciences and announced growth capital financing with Essex Woodlands Healthcare Partners last week.

Nationwide manufacturing issues have shrunk the supply of liquid forms of morphine, fentanyl and Dilaudid, which are injected to control acute pain after surgery, VC Star reports.

Ambulatory surgery centers are seeking new ways to reduce their supply chain costs without affecting day-to-day operations. However, many ASCs overlook one key way to improve their bottom line: reducing the amount spent on direct shipments to their facilities.

The Securities and Exchange Commission charged Theranos founder and CEO Elizabeth Holmes with massive fraud. Ms. Holmes will lose control of the company for defrauding investors and has agreed to pay a $500,000 fine.

Cardinal Health posted adjusted earnings of $1.31 a share last quarter, and its stock value has been on the rise because of it, increasing 7.5 percent over the last month, Zacks reports.

Abiomed will pay $3.1 million to settle allegations that it tried influencing doctors to use its Impella heart pump by treating them to lavish meals, MassDevice.com reports.

Grifols, a producer of plasma-derived medicines, entered a distribution agreement with Henry Schein, which will market and distribute Grifol's 500 milliliter normal saline solution in the U.S.

A 69-count indictment charged 12 individuals with operating a "pill mill" in Virginia and West Virginia.